Recommendations – ESGO Gynae-Oncology Guidelines

ESGO-ESMO-ESP Consensus Conference on Ovarian Cancer Update


In cooperation with the European Society of Medical Oncology (ESMO) and the European Society of Pathology (ESP), ESGO started the updating process of consensus recommendations for the management of ovarian cancer under the Chairmanship of Prof. Anna Fagotti (ESGO), Prof. Jonathan Ledermann (ESMO)  and Prof. Xavier Matias-Guiu Guia (ESP).

The consensus conference on ovarian cancer management with the participation of experts from the European Society of Gynaecological Oncology (ESGO), the European Society of Medical Oncology (ESMO) and the European Society of Pathology (ESP) will take place in June 15-16  in Valencia, Spain. The conference will include input of 45 top European and overseas key opinion leaders in the area from 17 countries. Methodologists from both ESGO and ESMO will participate at the conference providing support in methodology and medical writing. The outcomes of the consensus conference will be published in the ESMO Journal.

You can view the original article here:

ESGO-ESMO Consensus Conference on Ovarian Cancer (2019)


ESGO Recommendations for Ovarian Cancer Surgery

Chaired by Prof. Denis Querleu (France), this project was aimed at developing clinically relevant and evidence-based guidelines for the surgical management of patients with epithelial ovarian, fallopian tube, and peritoneal cancer throughout Europe.

The guidelines are focused on the role, objectives, and standards of the surgical management. Medical management is not addressed, as the standards of medical management (referred to as “chemotherapy”) were defined at the time of the consensus conference in collaboration with the European society of medical oncology (ESMO).



The ESGO Council nominated an International Expert Panel made of practicing clinicians who provide care to ovarian cancer patients and have demonstrated leadership and interest in the management of ovarian patients.

To ensure that the statements are evidence-based, the current literature, identified from a systematic search carried out in MEDLINE and selected websites, has been reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the Expert Panel (expert agreement).

The process included also an external evaluation of the guidelines. The ESGO Council established a large panel of practicing clinicians and patients independent from the Expert Panel to evaluate the guidelines (quantitative and qualitative evaluations). Responses were pooled and discussed by the Expert Panel to finalize the guidelines.